Liver Disease

Disease State Hub

Polls

Treatment

03/01/2023

Individuals with NASH and significant liver fibrosis have a higher risk for serious liver-related outcomes compared with those with simple steatosis. Which endpoint should be a target for treatment: NASH...

03/01/2023

Aspirin

Poll: Aspirin and Liver Cancer Risk

12/13/2018

Can regular aspirin use reduce liver cancer risk?

12/13/2018

Liver Disease

Poll: Diet and NAFLD Risk

08/14/2018

A diet heavy in what type of food could lead to an increased risk of non-alcoholic fatty liver disease?

08/14/2018

Liver Disease

Poll: DAAs and Liver Transplantation

07/18/2018

Could preemptive DAA treatment improve the safety of the transplantation of HCV-positive livers into HCV-negative individuals?

07/18/2018

Research Summaries

FDA Alert

FDA Approves First Treatment for Adults With NASH, Serious Liver Disease

03/21/2024

Anthony Calabro, MA

The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.

03/21/2024

FDA Alert

FDA Approves Liver-Directed Treatment for Adults With Metastatic Uveal Melanoma

09/11/2023

Anthony Calabro, MA

The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.

09/11/2023

Research Summary

Guideline Update from the American Diabetes Association for the Detection, Management of Patients With Diabetes, Nonalcoholic Fatty Liver Disease

06/28/2023

Based on recent scientific knowledge, the American Diabetes Association (ADA) released a set of updates including recommendations for the detection and management of nonalcoholic fatty liver disease in...

06/28/2023

research summary

CVD Risk Is Increased in Patients with HIV and NAFLD, Liver Fibrosis

04/26/2023

Leigh Precopio

To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...

04/26/2023

Research Summary

Direct-Acting Antiviral Therapy Lowers Mortality, Cancer Risk in Patients With Hepatitis C

02/01/2023

The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.

02/01/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4